We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.68%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$19.1B
AUM Growth
+$1.76B
Cap. Flow
+$154M
Cap. Flow %
0.81%
Top 10 Hldgs %
32.12%
Holding
703
New
28
Increased
257
Reduced
281
Closed
39

Top Buys

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$60.7M
2
JNJ icon
Johnson & Johnson
JNJ
+$58.3M
3
SCHW
Charles Schwab
SCHW
+$54M
4
ABBV icon
AbbVie
ABBV
+$52.9M
5
PANW icon
Palo Alto Networks
PANW
+$42.9M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$92.7M
2
EMR icon
Emerson Electric
EMR
+$57.2M
3
MELI icon
Mercado Libre
MELI
+$48.9M
4
AVGO icon
Broadcom
AVGO
+$38.9M
5
MU icon
Micron Technology
MU
+$37.7M

Sector Composition

Rank Sector Weight
1 Technology 36.63%
2 Healthcare 23.08%
3 Financials 11.48%
4 Consumer Discretionary 7.78%
5 Communication Services 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VMC icon
426
Vulcan Materials
VMC
$36.8B
$3.06M 0.02%
9,943
+335
+3% +$95.1K
FTV icon
427
Fortive
FTV
$18.2B
$3.02M 0.02%
61,604
-15,838
-20% -$780K
ARES icon
428
Ares Management
ARES
$28.1B
$2.97M 0.02%
18,555
+441
+2% +$79.5K
MLM icon
429
Martin Marietta Materials
MLM
$34.2B
$2.93M 0.02%
4,647
+161
+4% +$96K
CMG icon
430
Chipotle Mexican Grill
CMG
$43.9B
$2.91M 0.02%
74,285
-8,689
-10% -$391K
RJF icon
431
Raymond James Financial
RJF
$33.5B
$2.9M 0.02%
16,776
-2
-0% -$331
RMD icon
432
ResMed
RMD
$31.1B
$2.88M 0.02%
10,520
+721
+7% +$197K
CFG icon
433
Citizens Financial Group
CFG
$30.1B
$2.88M 0.02%
54,169
+6,824
+14% +$340K
PSX icon
434
Phillips 66
PSX
$82.9B
$2.87M 0.02%
21,081
-3,441
-14% -$441K
BDX icon
435
Becton Dickinson
BDX
$46.4B
$2.86M 0.02%
15,305
-7,772
-34% -$1.44M
NTRS icon
436
Northern Trust
NTRS
$21.8B
$2.85M 0.01%
21,173
+1,135
+6% +$146K
KMB icon
437
Kimberly-Clark
KMB
$37.6B
$2.81M 0.01%
22,594
LKQ icon
438
LKQ Corp
LKQ
$6.72B
$2.77M 0.01%
90,680
-34,108
-27% -$1.12M
FITB
439
Fifth Third Bancorp
FITB
$51.3B
$2.75M 0.01%
61,696
GEN icon
440
Gen Digital
GEN
$16.5B
$2.66M 0.01%
93,811
-17,905
-16% -$535K
XYZ
441
Block Inc
XYZ
$48.9B
$2.65M 0.01%
36,732
+439
+1% +$32.9K
ACGL icon
442
Arch Capital
ACGL
$36.5B
$2.65M 0.01%
29,239
-133
-0.5% -$11.9K
LNTH icon
443
Lantheus
LNTH
$6.51B
$2.64M 0.01%
51,531
-3,254
-6% -$203K
TREX icon
444
Trex
TREX
$4.4B
$2.64M 0.01%
51,062
HUM icon
445
Humana
HUM
$43.9B
$2.63M 0.01%
10,097
+227
+2% +$59.7K
ROST icon
446
Ross Stores
ROST
$80.8B
$2.63M 0.01%
17,226
-878
-5% -$125K
AVB icon
447
AvalonBay Communities
AVB
$27.5B
$2.62M 0.01%
13,568
YUM icon
448
Yum! Brands
YUM
$41.9B
$2.61M 0.01%
17,189
+78
+0.5% +$11.5K
ALGM icon
449
Allegro MicroSystems
ALGM
$7.86B
$2.6M 0.01%
+89,175
New +$2.88M
GPK icon
450
Graphic Packaging
GPK
$3.35B
$2.6M 0.01%
132,743
-17,793
-12% -$387K

Similar funds

Candriam SCA's Q3 2025 Portfolio in Review

As of Q3 2025, Candriam SCA held 703 positions worth $19.1B, up 10% from $17.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q3 2025 filing shows 28 new, 257 increased, 281 reduced and 39 closed positions. Its largest new stake was Banco Macro: 322,600 shares worth $13.6M. The largest sale was NVIDIA, an estimated $92.7M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2025 buy was Banco Macro: 322,600 shares worth $13.6M.
  • Candriam SCA added most to Nu Holdings in Q3 2025, an estimated $60.7M increase.
  • Candriam SCA's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $92.7M.
  • Candriam SCA fully exited Verona Pharma in Q3 2025, selling an estimated $20.5M.
  • Candriam SCA's ten largest holdings make up 32% of its $19.1B portfolio in Q3 2025.
  • Candriam SCA opened 28 new positions and closed 39 in Q3 2025.
  • Candriam SCA's portfolio value rose 10% quarter-over-quarter to $19.1B.

Based on Candriam SCA's 13F filing for Q3 2025, filed 6 Nov 2025.